Physician profile
James Berry
NPI 1245631100
$3,975.18
in general payments reported to CMS, 2019-2025
8 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $255 · 2021: $402 · 2022: $2,034 · 2023: $617 · 2024: $101 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $580 · Education: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $580.39 |
| Education | $301.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seaspine Orthopedics Corporation | $1,685.01 | 2022 | |
| Medical Device Business Services, INC. | $1,616.52 | 2019-2023 | |
| Stryker Corporation | $283.28 | 2023 | Serrato |
| Axogen | $176.93 | 2023-2025 | Avance Nerve Graft |
| Checkpoint Surgical, INC | $101.02 | 2024 | Checkpoint Stimulators |
| Medtronic, INC. | $48.70 | 2021-2025 | Catalyft Pl Expandable Interbody System |
| Amgen INC. | $41.06 | 2019 | |
| Abbott Laboratories | $22.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Berry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.